Stem cell-based therapies are thriving. In fact, pharmaceutical companies are increasingly investing in stem cell technology to develop innovative and potentially valuable new treatments for severe human diseases, including cancer and neurological disorders, such as multiple sclerosis, Alzheimer´s and Parkinson´s disease, mood disorders, brain tumors and even stroke.

The overall goal of the Stem Cell Technologies course is to train a new generation of researchers with the knowledge necessary to understand stem cell plasticity and consider innovative stem cell-based strategies for the treatment of a range of devastating disorders.

Registrations are open up to the 14th of November through the FenixEdu Platform.

The full program and more informations can be consulted at the course’s page.